Results 181 to 190 of about 1,723,253 (280)
ABSTRACT Identification of a chemical agent yields insights into its physicochemical properties. By examining the intrinsic characteristics and environment of a compound, information about its history can be gathered. The main objective of authentication/forensic approaches to chemicals is to trace the history of the compound's origin, regardless of ...
Carla Orlandi +6 more
wiley +1 more source
Decoding per- and polyfluoroalkyl substances (PFAS) in hepatocellular carcinoma: a multi-omics and computational toxicology approach. [PDF]
Hong Y +5 more
europepmc +1 more source
This review systematically compares the size‐dependent toxicity of microplastics and nanoplastics in the intestine, liver, kidney, lung, and brain. Particle size determines bioavailability, barrier penetration, and injury mechanisms. Because of their small size and high surface reactivity, NPs readily cross the intestinal epithelium and blood–brain ...
Yixian Cheng +14 more
wiley +1 more source
Efficiency of pharmaceutical toxicity prediction in computational toxicology. [PDF]
Uesawa Y.
europepmc +1 more source
Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit Validation. [PDF]
Hevener KE.
europepmc +1 more source
ABSTRACT Natural products (NPs) have historically yielded numerous therapeutic agents, yet their integration into modern drug discovery has been constrained by chemical complexity, low abundance, laborious dereplication, and limited target annotation.
Antonio Lavecchia
wiley +1 more source
Investigating the link between microplastic exposure (benzyl butyl phthalate) and neurodegenerative diseases using high-performance computational toxicology. [PDF]
Abdulrahman A.
europepmc +1 more source
Big-data and machine learning to revamp computational toxicology and its use in risk assessment. [PDF]
Luechtefeld T, Rowlands C, Hartung T.
europepmc +1 more source
ABSTRACT Opioid use disorder (OUD) remains a major global health challenge, and currently approved treatments (methadone, buprenorphine, and naltrexone) are all opioid receptor‐targeting drugs with limitations in access, adherence, stigma, and use in polysubstance use disorders. Because the dopamine D3 receptor (D3R) is enriched in limbic brain regions
Chia‐Kuei Wu +15 more
wiley +1 more source
Editorial: Leveraging artificial intelligence and open science for toxicological risk assessment
Marc Teunis +3 more
doaj +1 more source

